Washington, D.C.—NPA has partnered with Jefferies, Oppenheimer, and Think Equity in an invitation-only conference hosted by cbdMD, according to a press release.
The press release notes that state laws and FDA inaction have muddled the cannabidiol (CBD) marketplace. To clarify the landscape, the conference—“Regulatory Roadmap for the CBD Industry”—will focus on discussing the regulatory climate. Lance Blundell, Esq. General Counsel for cbdMD, will moderate; Owen Bennett from Jefferies, Rupesh Parikh from Oppenheimer & Co., and Ashok Kumar from Think Equity will have a Q&A with Daniel Fabricant, Ph.D., President and CEO of NPA.
Related: Industry Groups Have Mixed Reactions to Legislation to Regulate CBD
Bill to Expand HSA and FSA for Nutritional Supplements Introduced in Senate
NH Proposes Regulations for CBD Products
While participants will be invitation only at the request of the sponsors, a transcript of the conference will be made available to the public on October 26.